Trial Profile
Phase III study of Belagenpumatucel-L in patients with Non-Small Cell Lung Cancer
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 11 Jul 2016
Price :
$35
*
At a glance
- Drugs Belagenpumatucel-L (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 11 Jul 2016 New trial record